作者:
Bygrave, Ceri A. [1]
;
Pawlyn, Charlotte [2]
;
Davies, Faith E. [3]
;
Cairns, David [4]
;
Striha, Alina [5]
;
Hockaday, Anna [6]
;
Paterson, Andrea [7]
;
Jones, John R. [8]
;
Kishore, Bhuvan [9]
;
Garg, Mamta [10]
;
Williams, Cathy [11]
;
Karunanithi, Kamaraj [12]
;
Lindsay, Jindriska [13]
;
Jenner, Matthew W. [14]
;
Cook, Gordon [15]
;
Drayson, Mark T. [16]
;
Owen, Roger G. [17]
;
Russel, Nigel H. [18]
;
Gregory, Walter M. ;
Morgan, Gareth J. ;
Jackson, Graham ;
Kaiser, Martin
作者单位:
Univ Arkansas, Myeloma Inst, Little Rock, AR 72204 USA
[1]
NCCC Freeman Rd Hosp, Dept Haematol, Newcastle Upon Tyne, Tyne & Wear, England
[2]
Leeds Inst Clin Trials Res, Clin Trials Res Unit, Leeds, W Yorkshire, England
[3]
Inst Canc Res, Sutton, Surrey, England
[4]
Univ Birmingham, Birmingham, W Midlands, England
[5]
St James Univ Hosp, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England
[6]
Univ Hosp Wales, Cardiff, S Glam, Wales
[7]
Univ Hosp North Midlands, Stoke On Trent, Staffs, England
[8]
Leicester Royal Infirm, Leicester, Leics, England
[9]
Heart England Fdn Trust, Birmingham, W Midlands, England
[10]
Univ Nottingham, Nottingham, England
[11]
Myeloma Inst Res & Therapy, Little Rock, AR USA
[12]
Inst Canc Res, Div Mol Pathol, London, England
[13]
Kent & Canterbury NHS Trust, Canterbury, Kent, England
[14]
St James Univ Hosp, Dept Haematol, Leeds Canc Ctr, Leeds, W Yorkshire, England
[15]
Nottingham Univ Hosp, Ctr Clin Haematol, Nottingham, England
[16]
Univ Hosp Southampton NHS Fdn Trust, Dept Haematol, Southampton, Hants, England
[17]
Inst Canc Res, London, England
[18]
发布时间
2020-08-21